Mako Ikeda

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Metastatic Breast Cancer

Affordable Care Act

Patient Reported

Chronic Kidney Disease

Top Venues

Breast cancer (Tokyo, Japan)

Anticancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Mako Ikeda, Yuki Kataoka, Tomoe Taji, Hirofumi Suwa, Hideko Nakagoshi
Half Dose Pegfilgrastim for Patients With Breast Cancer During Chemotherapy: A Case-series. Anticancer research 43 (3) (2023)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)
Tomoe Taji, Nina Odan, Yuki Kataoka, Mako Ikeda, Ai Yamaguchi, Eiji Suzuki, Hirofumi Suwa
Promoters of BRCA testing under insurance coverage for non-metastatic breast cancer patients in Japan: a retrospective cohort study. Breast cancer (Tokyo, Japan) 30 (2) (2022)